Journal of Cancer,
Год журнала:
2024,
Номер
15(10), С. 2994 - 3009
Опубликована: Янв. 1, 2024
Background:
Recently,
various
evidence
has
confirmed
that
Tyrosine
Kinase
with
Immunoglobulin-like
and
EGF-like
domains
1
(TIE1)
promotes
tumor
growth
in
many
cancers.However,
the
precise
mechanism
underlying
TIE1's
involvement
Gastric
Cancer
(GC)
remains
elusive.This
research
aimed
to
investigate
biological
function
of
TIE1
regulating
GC
progression.Methods:
The
Genome
Atlas
(TCGA),
Gene
Expression
Omnibus
(GEO),
GEPIA2.0,Sangerbox3.0
TIMER
databases
were
used
analyze
expression.Immunohistochemistry
(IHC)
was
demonstrate
expression
TIE1.TCGA,
GEPIA2.0
Kaplan-Meier
utilized
for
survival
analysis
explore
association
clinicopathological
features.Protein-Protein
Interaction
(PPI)
networks
constructed
using
Cytoscape.The
potential
molecular
investigated
by
Ontology
(GO),
Kyoto
Encyclopedia
Genomes
(KEGG),
Set
Enrichment
Analysis
(GSEA).We
studied
relationships
between
mutations,
immune
checkpoints
(ICs),
mutational
burden
(TMB),
as
well
microsatellite
instability
(MSI)
immunity
GC.Results:
Compared
normal
tissue,
significantly
overexpressed
tissues
(p
=
0.0072)
associated
poor
(P
<
0.05).According
GO
KEGG
enrichment
analyses,
enriched
signal
pathways
related
occurrence,
invasion,
migration
malignant
tumors
(i.e.,
PI3K-Akt
signaling
pathway,
Calcium
etc.).Immune
infiltration
suggested
is
positively
correlated
macrophages
M2
negatively
Mast
cells,
naive
B
cells
Follicular
helper
T
(TFH),
which
may
be
a
contributing
factor
progression.Furthermore,
on
microenvironment
(TME)
purity
also
proved
an
oncogene.Mutation
showed
high
group
had
higher
frequency
mutations
TP53
ARID1,
while
TMB
score
lower.Conclusion:
might
oncogene
via
dysregulated
cause
immunosuppression
could
identified
biomarker
prognosis
therapeutic
target
GC.
Cell Death and Disease,
Год журнала:
2025,
Номер
16(1)
Опубликована: Фев. 7, 2025
Abstract
Gastric
cancer
(GC)
remains
a
leading
cause
of
cancer-related
mortality
worldwide,
with
limited
treatment
options
in
advanced
stages.
Immunotherapy,
particularly
immune
checkpoint
inhibitors
(ICIs)
targeting
PD1/PD-L1,
has
emerged
as
promising
therapeutic
approach.
However,
significant
proportion
patients
exhibit
primary
or
acquired
resistance,
limiting
the
overall
efficacy
immunotherapy.
This
review
provides
comprehensive
analysis
mechanisms
underlying
immunotherapy
resistance
GC,
including
role
tumor
microenvironment,
dynamic
PD-L1
expression,
compensatory
activation
other
checkpoints,
and
genomic
instability.
Furthermore,
explores
GC-specific
factors
such
molecular
subtypes,
unique
evasion
mechanisms,
impact
Helicobacter
pylori
infection.
We
also
discuss
emerging
strategies
to
overcome
combination
therapies,
novel
immunotherapeutic
approaches,
personalized
based
on
genomics
microenvironment.
By
highlighting
these
key
areas,
this
aims
inform
future
research
directions
clinical
practice,
ultimately
improving
outcomes
for
GC
undergoing
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Март 3, 2025
Gastric
cancer
(GC)
remains
a
significant
global
health
concern
due
to
its
poor
prognosis
and
limited
therapeutic
options,
particularly
in
advanced
stages.
Tumor
microenvironment
(TME),
tumor-associated
macrophages
(TAMs),
plays
key
role
tumor
progression,
immune
evasion,
therapy
resistance.
TAMs
exhibit
plasticity,
shifting
between
pro-inflammatory
M1
immunosuppressive
M2
phenotypes,
with
the
latter
predominating
GC
contributing
outcomes.
Recent
advancements
focus
on
targeting
TAMs,
including
inhibiting
polarization,
reprogramming
combining
TAM-targeted
approaches
checkpoint
inhibitors.
Innovations
nanotechnology,
metabolic
reprogramming,
pathways
such
as
interleukin-6
C-C
motif
ligand
2/C-C
chemokine
receptor
2
further
enhance
these
strategies.
However,
challenges
remain,
spatial
functional
heterogeneity
of
within
TME
need
for
selective
avoid
disrupting
homeostasis.
Ongoing
research
TAM
origins,
functions,
interactions
is
crucial
developing
precise
effective
therapies.
These
advances
hold
promise
not
only
improving
outcomes
but
also
addressing
other
cancers
similarly
complex
microenvironments.
Clinical and Translational Medicine,
Год журнала:
2023,
Номер
13(8)
Опубликована: Авг. 1, 2023
Gastric
cancer
(GC)
is
a
malignant
tumour,
with
high
morbidity
and
mortality
rates
worldwide.
The
occurrence
development
of
GC
complex
process
involving
genetic
changes
in
tumour
cells
the
influence
surrounding
microenvironment
(TME).
Accumulative
evidence
shows
that
tumour-associated
macrophages
(TAMs)
play
vital
role
GC,
acting
as
plentiful
active
infiltrating
inflammatory
TME.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(13), С. 7346 - 7346
Опубликована: Июль 4, 2024
Regulatory
T
cells
(Tregs)
possess
unique
immunosuppressive
activity
among
CD4-positive
cells.
Tregs
are
ubiquitously
present
in
mammals
and
function
to
calm
excessive
immune
responses,
thereby
suppressing
allergies
or
autoimmune
diseases.
On
the
other
hand,
due
their
function,
thought
promote
cancer
progression.
The
tumor
microenvironment
(TME)
is
a
multicellular
system
composed
of
many
cell
types,
including
cells,
infiltrating
cancer-associated
fibroblasts
(CAFs).
Within
this
environment,
recruited
by
chemokines
metabolic
factors
impede
effective
anti-tumor
responses.
However,
some
cases,
presence
can
also
improve
patient's
survival
rates.
Their
functional
consequences
may
vary
across
locations,
stages.
An
in-depth
understanding
precise
roles
mechanisms
actions
Treg
crucial
for
developing
treatments,
emphasizing
need
further
investigation
validation.
This
review
aims
provide
comprehensive
overview
complex
multifaceted
within
TME,
elucidating
cellular
communications,
signaling
pathways,
impacts
on
progression
highlighting
potential
through
interactions
with
molecules.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 30, 2025
Abstract
BTB
domain
and
CNC
homolog
1
(BACH1)
belongs
to
the
family
of
basic
leucine
zipper
proteins
is
expressed
in
most
mammalian
tissues.
It
can
regulate
its
own
expression
play
a
role
transcriptionally
activating
or
inhibiting
downstream
target
genes.
has
crucial
various
biological
processes,
such
as
oxidative
stress,
cell
cycle,
heme
homeostasis,
immune
regulation.
Recent
research
highlights
BACH1's
significant
regulatory
roles
series
conditions,
including
stem
pluripotency
maintenance
differentiation,
growth,
senescence,
apoptosis.
BACH1
closely
associated
with
cardiovascular
diseases
contributes
angiogenesis,
atherosclerosis,
restenosis,
pathological
cardiac
hypertrophy,
myocardial
infarction,
ischemia/reperfusion
(I/R)
injury.
promotes
tumor
proliferation
metastasis
by
altering
metabolism
epithelial‐mesenchymal
transition
phenotype.
Moreover,
appears
show
an
adverse
neurodegenerative
diseases,
gastrointestinal
disorders,
leukemia,
pulmonary
fibrosis,
skin
diseases.
Inhibiting
may
be
beneficial
for
treating
these
This
review
summarizes
mechanism
different
types
proposing
that
precise
targeted
intervention
provide
new
strategies
human
disease
prevention
treatment.
Molecules,
Год журнала:
2024,
Номер
29(8), С. 1843 - 1843
Опубликована: Апрель 18, 2024
Purpose:
To
investigate
and
systematically
describe
the
mechanism
of
action
Prunella
vulgaris
(P.
vulgaris)
against
digestive
system
tumors
related
toxicity
reduction.
Methods:
This
study
briefly
describes
history
medicinal
food
pharmacological
effects
P.
vulgaris,
focusing
on
review
anti-digestive
tumor
active
ingredients
its
Results:
The
may
exert
anti-tumor
by
inducing
apoptosis
cancer
cells,
inhibiting
angiogenesis,
migration
invasion
autophagy.
In
addition,
inhibit
release
inflammatory
factors
macrophages
increase
level
indicators
oxidative
stress
through
modulation
target
genes
in
pathway
to
achieve
effect
Conclusion:
medicine
homology
plant
not
only
treat
different
mechanisms
but
also
reduce
toxic
effects.
is
worthy
being
explored
more
deeply.
International Journal of Oncology,
Год журнала:
2024,
Номер
64(6)
Опубликована: Апрель 30, 2024
Tumor‑associated
macrophages
(TAMs)
are
essential
components
of
the
tumor
microenvironment
(TME)
and
display
phenotypic
heterogeneity
plasticity
associated
with
stimulation
bioactive
molecules
within
TME.
TAMs
predominantly
exhibit
tumor‑promoting
phenotypes
involved
in
progression,
such
as
angiogenesis,
metastasis,
immunosuppression
resistance
to
therapies.
In
addition,
have
potential
regulate
cytotoxic
elimination
phagocytosis
cancer
cells
interact
other
immune
engage
innate
adaptive
systems.
this
context,
targeting
has
been
a
popular
area
research
therapy,
comprehensive
understanding
complex
role
progression
exploration
macrophage‑based
therapeutic
approaches
for
future
therapeutics
against
cancers.
The
present
review
provided
updated
overview
function
summarized
recent
advances
TAM‑targeting
strategies
discussed
obstacles
perspectives
therapies
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Фев. 13, 2025
The
incidence
of
gastric
cancer
remains
high
and
poses
a
serious
threat
to
human
health.
Recent
comprehensive
investigations
into
amino
acid
metabolism
immune
system
components
within
the
tumor
microenvironment
have
elucidated
functional
interactions
between
cells,
metabolism.
This
study
reviews
characteristics
in
cancer,
with
particular
focus
on
methionine,
cysteine,
glutamic
acid,
serine,
taurine,
other
acids.
It
discusses
relationship
these
metabolic
processes,
development,
body’s
anti-tumor
immunity,
analyzes
importance
targeting
for
chemotherapy
immunotherapy.
Computational and Structural Biotechnology Journal,
Год журнала:
2024,
Номер
23, С. 990 - 1004
Опубликована: Фев. 7, 2024
Cell
pyroptosis,
a
Gasdermin-dependent
programmed
cell
death
characterized
by
inflammasome,
plays
complex
and
dynamic
role
in
Gastric
cancer
(GC),
serious
threat
to
human
health.
Therefore,
the
value
of
pyroptosis-related
genes
(PRGs)
as
prognostic
biomarkers
therapeutic
indicators
for
patients
needs
be
exploited
GC.
This
study
integrates
single-cell
RNA
sequencing
(scRNA-seq)
dataset
GSE183904
with
GC
transcriptome
data
from
TCGA
database,
focusing
on
expression
distribution
PRGs
at
level.
The
signature
was
established
using
Cox
LASSO
analyses.
differences
long-term
prognosis,
immune
infiltration,
mutation
profile,
CD274
response
chemotherapeutic
drugs
between
two
groups
were
analyzed
evaluated.
A
tissue
array
used
verify
six
PRGs,
CD274,
CD163
FoxP3.
C12orf75,
VCAN,
RGS2,
MKNK2,
SOCS3
TNFAIP2
successfully
screened
out
establish
potently
predict
survival
time
patients.
webserver
(https://pumc.shinyapps.io/GastricCancer/)
prediction
developed
based
this
signature.
High-risk
score
typically
had
worse
prognoses,
resistance
classical
chemotherapy,
more
immunosuppressive
tumor
microenvironment.
greatly
elevated
while
RGS2
MKNK2
decreased
samples.
Further,
VCAN
positively
related
infiltrations
Tregs
M2
TAMs
TME
cells.
In
summary,
potent
accurately
forecast
treatment
responsiveness